Ferguson Wellman Capital Management Inc. Has $1.17 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Ferguson Wellman Capital Management Inc. cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,838 shares of the financial services provider’s stock after selling 330 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,168,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. SPC Financial Inc. increased its position in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management grew its holdings in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares during the period. Chicago Partners Investment Group LLC grew its holdings in iShares Biotechnology ETF by 2.5% in the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after purchasing an additional 94 shares during the period. Capital Investment Advisors LLC grew its holdings in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after purchasing an additional 99 shares during the period. Finally, Magnus Financial Group LLC grew its holdings in iShares Biotechnology ETF by 0.8% in the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after purchasing an additional 104 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $136.15 on Tuesday. The firm has a fifty day simple moving average of $136.10 and a two-hundred day simple moving average of $141.27. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.